- Home
- SBFM vs ATCH Comparison
SBFM vs ATCH Comparison
Compare SBFM & ATCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFM
- ATCH
- Stock Information
- Founded
- SBFM 2006
- ATCH 2022
- Country
- SBFM United States
- ATCH United States
- Employees
- SBFM N/A
- ATCH N/A
- Industry
- SBFM Biotechnology: Pharmaceutical Preparations
- ATCH
- Sector
- SBFM Health Care
- ATCH
- Exchange
- SBFM Nasdaq
- ATCH Nasdaq
- Market Cap
- SBFM 3.7M
- ATCH 3.7M
- IPO Year
- SBFM N/A
- ATCH N/A
- Fundamental
- Price
- SBFM $2.35
- ATCH $0.17
- Analyst Decision
- SBFM
- ATCH
- Analyst Count
- SBFM 0
- ATCH 0
- Target Price
- SBFM N/A
- ATCH N/A
- AVG Volume (30 Days)
- SBFM 151.4K
- ATCH 11.0M
- Earning Date
- SBFM 11-05-2024
- ATCH 11-29-2024
- Dividend Yield
- SBFM N/A
- ATCH N/A
- EPS Growth
- SBFM N/A
- ATCH N/A
- EPS
- SBFM N/A
- ATCH 0.04
- Revenue
- SBFM $32,959,491.00
- ATCH N/A
- Revenue This Year
- SBFM $86.70
- ATCH N/A
- Revenue Next Year
- SBFM $126.76
- ATCH N/A
- P/E Ratio
- SBFM N/A
- ATCH $4.04
- Revenue Growth
- SBFM 61.94
- ATCH N/A
- 52 Week Low
- SBFM $2.25
- ATCH $0.12
- 52 Week High
- SBFM $638.00
- ATCH $10.26
- Technical
- Relative Strength Index (RSI)
- SBFM 25.54
- ATCH 44.35
- Support Level
- SBFM $2.58
- ATCH $0.17
- Resistance Level
- SBFM $2.86
- ATCH $0.26
- Average True Range (ATR)
- SBFM 0.17
- ATCH 0.04
- MACD
- SBFM -0.04
- ATCH 0.00
- Stochastic Oscillator
- SBFM 12.67
- ATCH 12.92
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. The company is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA targeted for liver cancer, (ii) SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections, and (iii) Adva-27a for pancreatic cancer. The company has two reportable segments: Prescription Generic Pharmaceuticals ("Generic Pharmaceuticals") and Nonprescription Over-The-Counter Products ("OTC Products"). The company generates the majority of its revenue from the Generic Pharmaceuticals segment.
About ATCH AtlasClear Holdings Inc. Common Stock
AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and innovative financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.